Skip to main content
Caplight Logo









Stemden

Stemden

Private
YangsanHealthcare & Life Scienceshttp://stemden.org/

Last Round

Seed

Jan 15, 2026

Total Funding Raised

$185,000

Company Overview

Stemden is a biotechnology company that develops oral tissue regeneration treatments using cell activation-based technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinedental biotechnologytissue regenerationstem cell therapydental regenerationbiomaterialsperiodontal regenerationalveolar bone regenerationpulp-dentin regenerationregenerative dentistrymedtechdental innovationbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stemden Comparables

Compare Stemden with similar companies based on industry and business-model similarity.

Stemden comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HysensBio
83%
Mintech-Bio
74%
Toregem BioPharma
74%

Stemden Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 15, 2026
GrantOct 30, 2024
SeedJun 1, 2022

Stemden Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    $110K grant received from Startup SG.

Stemden Filings

Explore SEC and related filing metadata, where available.

Stemden filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stemden's valuation, stock price, and market status.

Is Stemden a public or private company?

Stemden is a private company.

What is the current stock price of Stemden?

Stemden is a private company with no public stock price. No recent secondary market data is available.

How much is Stemden worth (valuation)?

Valuation information for Stemden is not publicly available.

Can I buy Stemden stock?

Stemden shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stemden's last funding round?

Stemden's most recent funding round was Seed on January 15, 2026.

Who are the main investors in Stemden?

Key investors in Stemden include Enterprise Singapore, TIPS (Tech Incubator Program for Startup), C&Venture Partners.

Will Stemden IPO soon?

No public IPO plans have been announced for Stemden.

How can I track Stemden secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stemden's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersYangsan
Year Founded2021
Last FundingJan 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?